Journal of Medical Economics, Volume 23, Issue 6 (2020)

Browse this journal
Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days

Journal of Medical Economics, Volume 23, Issue 6 (2020)

See all volumes and issues
Vol 27, 2024 Vol 26, 2023 Vol 25, 2022 Vol 24, 2021 Volume 23, 2020 Vol 22, 2019 Vol 21, 2018 Vol 20, 2017 Vol 19, 2016 Vol 18, 2015 Vol 17, 2014 Vol 16, 2013 Vol 15, 2012 Vol 14, 2011 Vol 13, 2010 Vol 12, 2009 Vol 11, 2008 Vol 10, 2007 Vol 9, 2006 Vol 8, 2005 Vol 7, 2004 Vol 6, 2003 Vol 5, 2002 Vol 4, 2001 Vol 3, 2000 Vol 2, 1999 Vol 1, 1998
Download citations Download PDFs Download issue

Haematology

Article
Real-world annualized healthcare utilization and expenditures among insured US patients with acute intermittent porphyria (AIP) treated with hemin
Barbara Blaylock, Josh Epstein & Paul Stickler
Pages: 537-545
Published online: 13 Feb 2020
AbstractforReal-world annualized healthcare utilization and expenditures among insured US patients with acute intermittent porphyria (AIP) treated with hemin | Full Text | References | PDF (910.9 KB) | EPUB
  • 2587 Views
  • 4 CrossRef citations
  • 0Altmetric
Open Access

Mental Health

Review Article
Patients’ preferences for the treatment of anxiety and depressive disorders: a systematic review of discrete choice experiments
Maike Tünneßen, Mickaël Hiligsmann, Stephanie Stock & Vera Vennedey
Pages: 546-556
Published online: 24 Feb 2020
AbstractforPatients’ preferences for the treatment of anxiety and depressive disorders: a systematic review of discrete choice experiments | Full Text | References | PDF (1.6 MB) | EPUB | Supplemental
  • 2877 Views
  • 16 CrossRef citations
  • 0Altmetric
Open Access

Healthcare Systems

Article
Evaluation of four disease management programs: evidence from blue cross blue shield of Louisiana
M. Liu, X. Yuan, J. Ouyang, J. Chaisson, T. Bergeron, D. Cantrell, V. Washington, Y. Zhang & S. Nigam
Pages: 557-565
Published online: 13 Feb 2020
AbstractforEvaluation of four disease management programs: evidence from blue cross blue shield of Louisiana | Full Text | References | PDF (1.1 MB) | EPUB
  • 3990 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access
Article
Economic impact of industry-sponsored clinical trials of pharmaceutical products in Austria
Evelyn Walter, Gerald Eichhober, Marco Voit, Christian Baumgartner, Alexander Celedin, Christa Holzhauser, Bernhard Mraz, Christina Ornauer, Johannes Pleiner-Duxneuner, Botond Ponner, Isabella Presch, Georg Pum, Helga Tieben, Gertrude Weingartmann, Dejan Baltic, Wolfgang Bonitz & Stefan Thomas Kaehler
Pages: 566-574
Published online: 04 Mar 2020
AbstractforEconomic impact of industry-sponsored clinical trials of pharmaceutical products in Austria | Full Text | References | PDF (1.1 MB) | EPUB | Supplemental
  • 2330 Views
  • 5 CrossRef citations
  • 0Altmetric
Free Access

Oncology

Article
Cost-effectiveness of six months versus 1-year adjuvant trastuzumab in HER2 positive early breast cancer in Egypt
Gihan Hamdy Elsisi, Yousery Nada, Noha Rashad, João Carapinha, Ahmad O. Noor, Diena M. Almasri, Mostafa Al Zaidy, Ahmed Foad & Hussien Khaled
Pages: 575-580
Published online: 24 Feb 2020
AbstractforCost-effectiveness of six months versus 1-year adjuvant trastuzumab in HER2 positive early breast cancer in Egypt | Full Text | References | PDF (952.5 KB) | EPUB
  • 2166 Views
  • 3 CrossRef citations
  • 0Altmetric
Free Access
Article
Projecting total costs and health consequences of increasing mt-sDNA utilization for colorectal cancer screening from the payer and integrated delivery network perspectives
Joanne M. Hathway, Lesley-Ann Miller-Wilson, Ivar S. Jensen, Burak Ozbay, Catherine Regan, Anupam B. Jena, Milton C. Weinstein & Philip D. Parks
Pages: 581-592
Published online: 11 Apr 2020
AbstractforProjecting total costs and health consequences of increasing mt-sDNA utilization for colorectal cancer screening from the payer and integrated delivery network perspectives | Full Text | References | PDF (1.3 MB) | EPUB | Supplemental
  • 3569 Views
  • 7 CrossRef citations
  • 0Altmetric
Open Access
Article
A cost analysis of SIR-Spheres yttrium-90 resin microspheres versus tyrosine kinase inhibitors in the treatment of unresectable hepatocellular carcinoma in France, Italy, Spain and the UK
Richard F. Pollock, Fabien Colaone, Laura Guardiola, Suki Shergill & Victoria K. Brennan
Pages: 593-602
Published online: 01 May 2020
AbstractforA cost analysis of SIR-Spheres yttrium-90 resin microspheres versus tyrosine kinase inhibitors in the treatment of unresectable hepatocellular carcinoma in France, Italy, Spain and the UK | Full Text | References | PDF (1.4 MB) | EPUB | Supplemental
  • 4174 Views
  • 6 CrossRef citations
  • 0Altmetric
Open Access

Infectious Disease

Article
Healthcare resource utilization and direct medical costs associated with index and recurrent Clostridioides difficile infection: a real-world data analysis
Paul Feuerstadt, Laura Stong, David N. Dahdal, Naomi Sacks, Kathleen Lang & Winnie W. Nelson
Pages: 603-609
Published online: 13 Feb 2020
AbstractforHealthcare resource utilization and direct medical costs associated with index and recurrent Clostridioides difficile infection: a real-world data analysis | Full Text | References | PDF (861 KB) | EPUB
  • 5264 Views
  • 31 CrossRef citations
  • 0Altmetric
Open Access

Rheumatology

Review Article
Cost-utility analyses of targeted immunomodulators in rheumatoid arthritis: systematic review
Matthew Sussman, Charles Tao, Pankaj Patel, Namita Tundia, Jerry Clewell & Joseph Menzin
Pages: 610-623
Published online: 07 Feb 2020
AbstractforCost-utility analyses of targeted immunomodulators in rheumatoid arthritis: systematic review | Full Text | References | PDF (1.2 MB) | EPUB
  • 2342 Views
  • 2 CrossRef citations
  • 0Altmetric
Open Access
Article
A budget impact analysis for making treatment decisions based on anti-cyclic citrullinated peptide (anti-CCP) testing in rheumatoid arthritis
Sang Hee Park, Xue Han, Francis Lobo, David Kratochvil & Dipen Patel
Pages: 624-630
Published online: 19 May 2020
AbstractforA budget impact analysis for making treatment decisions based on anti-cyclic citrullinated peptide (anti-CCP) testing in rheumatoid arthritis | Full Text | References | PDF (705.2 KB) | EPUB | Supplemental
  • 1934 Views
  • 1 CrossRef citations
  • 0Altmetric
Open Access

Musculoskeletal

Article
Cost effectiveness and impact on quality of life of abobotulinumtoxinA and onabotulinumtoxinA in the treatment of children with lower limb spasticity in Canada
Karissa Johnston, Natalya Danchenko, Ryan Hansen, Jerome Dinet, Anna Liovas, Ava Armstrong, Savreet Bains & Sean D. Sullivan
Pages: 631-640
Published online: 07 Feb 2020
AbstractforCost effectiveness and impact on quality of life of abobotulinumtoxinA and onabotulinumtoxinA in the treatment of children with lower limb spasticity in Canada | Full Text | References | PDF (1.2 MB) | EPUB | Supplemental
  • 2595 Views
  • 1 CrossRef citations
  • 0Altmetric
Open Access

Immunology

Article
Effectiveness comparison and incremental cost-per-responder analysis of calcipotriene 0.005%/betamethasone dipropionate 0.064% foam vs. halobetasol 0.01%/tazarotene 0.045% lotion for plaque psoriasis: a matching-adjusted indirect comparative analysis
Jashin J. Wu, Jes B. Hansen, Dharm S. Patel, Nanna Nyholm, Karen A. Veverka & Andrine R. Swensen
Pages: 641-649
Published online: 02 Mar 2020
AbstractforEffectiveness comparison and incremental cost-per-responder analysis of calcipotriene 0.005%/betamethasone dipropionate 0.064% foam vs. halobetasol 0.01%/tazarotene 0.045% lotion for plaque psoriasis: a matching-adjusted indirect comparative analysis | Full Text | References | PDF (1.2 MB) | EPUB | Supplemental
  • 2777 Views
  • 4 CrossRef citations
  • 0Altmetric
Open Access

Diabetes

Article
Oral semaglutide versus injectable glucagon-like peptide-1 receptor agonists: a cost of control analysis
B. B. Hansen, S. Nuhoho, S. N. Ali, T. Dang-Tan, W. J. Valentine, S. J. P. Malkin & B. Hunt
Pages: 650-658
Published online: 07 Feb 2020
AbstractforOral semaglutide versus injectable glucagon-like peptide-1 receptor agonists: a cost of control analysis | Full Text | References | PDF (1 MB) | EPUB
  • 8255 Views
  • 19 CrossRef citations
  • 0Altmetric
Open Access

Cardiovascular Medicine

Article
Cost-effective analysis of clopidogrel versus aspirin for high risk patients with established peripheral arterial disease in China
Ziyi Lin, Lei Zhang, Xiaoyan Yang, Li Liu & Jianwei Xuan
Pages: 659-666
Published online: 24 Feb 2020
AbstractforCost-effective analysis of clopidogrel versus aspirin for high risk patients with established peripheral arterial disease in China | Full Text | References | PDF (895.7 KB) | EPUB
  • 1289 Views
  • 0 CrossRef citations
  • 0Altmetric
Free Access

Explore articles

Explore the most recently published articles

Intensive care unit improves dialysis care quality while reducing costs
Tara Greenleaf Nichols et al.
Research Letter | Published online: 7 Jun 2024
Open Access
The efficiency of TAVI in intermediate and low-risk Japanese patients
Panagiotis Petrou
Editorial | Published online: 7 Jun 2024
Open Access
Analysis of long-term clinical and cost impact of etranacogene dezaparvovec for the treatment of hemophilia B population in the United States
Songkai Yan et al.
Article | Published online: 6 Jun 2024
Open Access
Cost-effectiveness analysis of mosunetuzumab for treatment of relapsed or refractory follicular lymphoma after two or more lines of systemic therapy in the United States
Matthew Matasar et al.
Article | Published online: 6 Jun 2024
Open Access
View all latest articles